COULD COVID-19 TRIGGER TYPE 1 DIABETES? PRESENTATION OF COVID-19 CASE PRESENTED WITH DIABETIC KETOACIDOSIS

• Published in: Acta endocrinologica (Bucharest, Romania : 2005) Vol. 17; no. 4; pp. 532 - 536
• Main Authors: Genç, S, Evren, B, Bozbay, A, Aydın, E Ş, Genç, Ö, Şahin, I
• Format: Journal Article
• Language: English
• Published: Romania Carol Davila University Press 01.10.2021
• Subjects: Case Report; Diabetic Ketoacidosis; Type 1 Diabetes; Covid-19
• ISSN: 1841-0987; 1843-066X
• DOI: 10.4183/aeb.2021.532

COVID-19 is a viral disease that is recognized now as a pandemic by the World Health Organization. It is known that some viral infections may trigger autoimmune diseases. It has been revealed that COVID-19 may also lead to the pathogenesis of some autoimmune diseases, including Type 1 DM (T1DM) and autoimmune thyroid diseases. Here, we aimed to present a young female patient with COVID-19, who we followed up in our clinic, who presented with diabetic ketoacidosis (DKA), and developed Hashimoto's disease during the treatment process. In order to emphasize that COVID-19 may trigger the emergence of T1DM, that it may mask nonspecific DKA symptoms like nausea and vomiting, that it may cause delay in diagnosis of DKA, and also to emphasize the importance of evaluating other autoimmune diseases accompanying COVID-19, we found it appropriate to present this case.